Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD‑L1 and MHC I in colon cancer cells-Reference-Cited by-同舟云学术

Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD‑L1 and MHC I in colon cancer cells

Published:2022-12-09 Issue:1 Volume:25 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Hassan Mohamed¹,Trung Vu²,Bedi Deepa¹,Shaddox Sage¹,Gunturu Dilip¹,Yates Clayton¹,Datta Pran²,Samuel Temesgen¹

Affiliation:

1. Tuskegee University College of Veterinary Medicine and Center for Biomedical Research, Tuskegee, AL 36088, USA

2. Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference36 articles.

1. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

2. Immunotherapy in colorectal cancer: Where are we now?;Baybutt;Curr Colorectal Cancer Rep,2017

3. Where we stand with immunotherapy in colorectal cancer: Deficient mismatch repair, proficient mismatch repair, and toxicity management;Overman;Am Soc Clin Oncol Educ Book,2018

4. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade;Le;Science,2017

5. Immunotherapy of metastatic colorectal cancer: Prevailing challenges and new perspectives;Zumwalt;Curr Colorectal Cancer Rep,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of 2‐Aryl Indazole: Synthesis, Biological Evaluationand In‐Silico Studies;Chemistry & Biodiversity;2024-06-12

2. Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy;Cancer Immunology, Immunotherapy;2024-04-02

3. Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review;Cancers;2024-02-06

4. Activation of STING by the Novel Liposomal TLC388 Enhances the Therapeutic Response to Anti-PD-1 Antibodies in Combination with Radiotherapy;2024-01-30

5. Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials;Small Methods;2023-09-24